Lumexa Imaging Holdings, Inc. Basic Shares Outstanding (Weighted Average)
Lumexa Imaging Holdings, Inc. (LMRI) reported Basic Shares Outstanding (Weighted Average) of 95.98 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- Lumexa Imaging Holdings, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 95.98M shares, a 38.05% increase year-over-year.
- Lumexa Imaging Holdings, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 95.98M shares, a 38.06% increase year-over-year.
- Lumexa Imaging Holdings, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 69.53M shares.
- Lumexa Imaging Holdings, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-03-31 was 69.52M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month |
|---|---|---|
| 2026-06-30 | 95.98M shares 10-Q · filed 2026-08-13 | 95.98M shares 10-Q · filed 2026-08-13 |
| 2026-03-31 | 95.98M shares 10-Q · filed 2026-05-12 | |
| 2025-06-30 | 69.53M shares 10-Q · filed 2026-08-13 | 69.52M shares 10-Q · filed 2026-08-13 |
| 2025-03-31 | 69.52M shares 10-Q · filed 2026-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B |